Home
CVAC

CVAC

CureVac N.V.

as of 12-03-2025 3:44pm EST

$5.17

+$0.05

+1.08%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Chart Type:

Time Range:

Founded:	2000	Country:	Germany
Employees:	N/A	City:	N/A
Market Cap:	1.2B	IPO Year:	2020
Target Price:	$6.83	AVG Volume (30 days):	1.6M
Analyst Decision:	Hold	Number of Analysts:	3
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	0.94	EPS Growth:	94.02
52 Week Low/High:	$2.48 - $5.72	Next Earning Date:	11-24-2025
Revenue:	$83,000,117	Revenue Growth:	-86.98%
Revenue Growth (this year):	-88.65%	Revenue Growth (next year):	23.40%

AI-Powered CVAC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 68.67%

68.67%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full CVAC Forecast & Prediction with Hourly Data

Compare CVAC vs Leading Stocks

See how CVAC stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free CVAC Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "CVAC CureVac N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.